| Product NDC: | 67386-411 |
| Proprietary Name: | Elspar |
| Non Proprietary Name: | asparaginase |
| Active Ingredient(s): | 10000 [iU]/1 & nbsp; asparaginase |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67386-411 |
| Labeler Name: | Lundbeck LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA101063 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19780110 |
| Package NDC: | 67386-411-51 |
| Package Description: | 1 VIAL in 1 CARTON (67386-411-51) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| NDC Code | 67386-411-51 |
| Proprietary Name | Elspar |
| Package Description | 1 VIAL in 1 CARTON (67386-411-51) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Product NDC | 67386-411 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | asparaginase |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19780110 |
| Marketing Category Name | BLA |
| Labeler Name | Lundbeck LLC |
| Substance Name | ASPARAGINASE |
| Strength Number | 10000 |
| Strength Unit | [iU]/1 |
| Pharmaceutical Classes | Asparaginase [Chemical/Ingredient],Asparagine-specific Enzyme [EPC] |